Enrylaze 10 mg/vial

Enrylaze 10 mg/vial is a medicine authorised by Swissmedic under authorisation number 69073. The authorisation holder is Jazz Pharmaceuticals Switzerland GmbH. The medicinal product code is Biotechnological medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 18 April 2024 and the authorisation is limited until 17 April 2029. ATC code L01XX02 places the medicine in the group Antineoplastic agents.

  • Dispensing category A
  • Authorisation number 69073
  • ATC L01XX02
  • Biotechnological medicines
Authorisation data
Authorisation number69073
NameEnrylaze 10 mg/vial
Full nameEnrylaze 10 mg/vial, Injektionslösung
Authorisation holderJazz Pharmaceuticals Switzerland GmbH
Medicinal product codeBiotechnological medicines
Dispensing categoryA · Prescription, not repeatable
ATC codeL01XX02
First authorisation18 April 2024
Authorisation validity17 April 2029
Strengths
No.NameDispensing categoryAuthorisation date
1Enrylaze 10 mg/vial, InjektionslösungA18 April 2024

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
13Durchstechflasche(n)L01XX0207.16.1.A

Scroll the table sideways

Other medicines from this authorisation holder

Frequently asked questions

Is Enrylaze 10 mg/vial authorised in Switzerland?

Yes. Enrylaze 10 mg/vial is authorised by Swissmedic under authorisation number 69073, data as of 01 September 2026. The authorisation is limited until 17 April 2029.

Which dispensing category does Enrylaze 10 mg/vial have?

Enrylaze 10 mg/vial is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Enrylaze 10 mg/vial?

The authorisation holder is Jazz Pharmaceuticals Switzerland GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com